Clinical overview
Clinical overview is an important endocrinology condition in dog practice. It is best understood as persistent hyperglycaemia caused by inadequate insulin effect. Clinical decisions should integrate signalment, history, examination findings and objective testing rather than relying on one isolated result. The practical aim is to recognise clinically important disease early, stabilise patients that are unwell, identify reversible or concurrent problems and establish a plan that owners can follow safely. This reference is intended for veterinary professionals and should be used with current product information, local formularies, antimicrobial stewardship policy and referral pathways. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Species and risk context
Risk assessment begins with species, age, breed, reproductive status, body condition, vaccination or preventive-care history, diet, environment and relevant previous disease. In dog patients, apparently similar signs may arise from very different mechanisms, so the pre-test probability created by signalment and history matters. Herd, household, kennel, cattery or yard context should be recorded where relevant because shared exposure can change both diagnosis and control. Concurrent endocrine, renal, gastrointestinal, infectious or inflammatory disease may modify presentation and treatment tolerance. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Epidemiology
The frequency of epidemiology varies with population, geography, preventive care, management system and referral bias. Published prevalence figures should therefore be interpreted in the population from which they were derived. Clinicians should focus on recognised risk patterns and local disease experience rather than treating a single prevalence estimate as universal. Earlier recognition is often associated with better opportunity for supportive care and prevention of complications, while delayed presentation can substantially change prognosis and resource requirements. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Aetiology and pathophysiology
The central disease process is persistent hyperglycaemia caused by inadequate insulin effect. The resulting physiological disturbance explains much of the observed presentation: polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. Disease severity reflects both the primary process and secondary effects such as dehydration, electrolyte disturbance, inflammation, altered perfusion, pain, infection or organ dysfunction. Understanding this chain is useful because treatment frequently needs to address several consequences simultaneously rather than targeting only the initiating cause. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Clinical presentation
Common presenting features include polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The pattern, duration and rate of progression are important. A complete examination should document hydration and perfusion, temperature, cardiovascular and respiratory status, pain, mentation, body condition and disease-specific findings. Mild or early disease can be subtle, whereas advanced disease may present primarily through systemic complications. Changes reported by the owner or stockperson are often clinically valuable when compared with the animal’s normal behaviour, intake, output and performance. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Red flags and emergencies
hypoglycaemia and diabetic ketoacidosis require urgent recognition. Emergency triage should prioritise airway, breathing and circulation where relevant, followed by pain control, perfusion, glucose and electrolyte abnormalities, temperature and immediate disease-specific threats. Stabilisation and diagnosis often proceed in parallel. Failure to improve as expected, rapidly changing observations or discordance between clinical appearance and initial tests should trigger reassessment rather than simple repetition of the original plan. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Differential diagnosis
Differentials should be organised by the dominant presenting problem and by what is dangerous or treatable to miss. Conditions causing similar changes in appetite, thirst, weight, gastrointestinal function, pain, lethargy, production or laboratory values should be considered. Medication effects, toxic exposure, dietary change, trauma and concurrent disease can mimic or complicate differential diagnosis. A ranked differential list is more useful than an exhaustive list because it links probability and consequence to the next diagnostic step. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Diagnostic approach
A practical diagnostic strategy is persistent hyperglycaemia with glucosuria; fructosamine and investigation of concurrent disease support interpretation. Testing should answer a defined clinical question and be interpreted alongside the patient rather than in isolation. Repeat measurements may be more informative than a single value when biological variation or changing disease is expected. Sampling before treatment is valuable when culture, cytology or other confirmatory testing may alter management, provided that doing so does not delay essential stabilisation. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Treatment and management
Core management includes insulin therapy, consistent feeding, body-condition management and home monitoring. Treatment intensity should match disease severity and the animal’s ability to eat, drink, maintain perfusion and tolerate outpatient care. Analgesia, fluid therapy, nutrition and nursing can be as important as disease-specific treatment. Plans should be revised in response to objective monitoring. Referral is appropriate when advanced imaging, intensive care, surgery or specialist expertise could materially alter outcome. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Medicines and safety
Medicines should be selected for a defined indication and dosed from a reliable veterinary formulary or authorised product information. Species differences, renal or hepatic function, hydration, pregnancy, age and concurrent medication can materially alter safety. For antimicrobials, stewardship principles require treatment to be justified and narrowed or stopped when evidence supports doing so. For food-producing animals, legal prescribing requirements and milk/meat withdrawal periods must be checked for the actual product and jurisdiction; this reference does not substitute for the current label or prescribing cascade. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Monitoring and prognosis
Monitoring should focus on clinical response and on the variables most likely to change management. Owners may be asked to track appetite, water intake, urine or faecal output, activity, pain, body weight, medication administration or other disease-specific observations. Recheck timing depends on severity and treatment risk. Prognosis should be communicated as a range influenced by disease stage, response to initial treatment, comorbidity, recurrence risk and the feasibility of ongoing care rather than as a single fixed percentage. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Prevention and biosecurity
Prevention is disease-specific but commonly includes vaccination where effective, good nutrition, weight management, hygiene, parasite control, environmental management and early attention to abnormal signs. Where infectious spread is plausible, isolation, cleaning and disinfection, equipment separation and movement control should be proportionate to risk. Herd or multi-animal settings require attention to population-level drivers; treating repeated individual cases without addressing management factors can leave the underlying problem unchanged. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Zoonotic and public-health considerations
For zoonotic and public-health considerations, zoonotic relevance and wider public-health implications should be considered explicitly rather than assumed. Some veterinary syndromes have little direct zoonotic importance, but infection control, antimicrobial resistance, food safety, occupational exposure or environmental contamination may still matter. When a zoonotic agent is suspected, clinicians should use appropriate PPE and local reporting or public-health pathways. Food-producing animal cases require particular attention to residues and food-chain obligations. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Owner or client communication
Good outcomes depend on clear communication about what is known, what remains uncertain, treatment goals, warning signs and the planned recheck. Owners should receive practical instructions that match their ability to administer medication, monitor the animal and return promptly if deterioration occurs. Costs and alternative care pathways should be discussed without compromising welfare. Written discharge information is especially useful for complex regimens, isolation instructions or conditions where day-to-day trends are more informative than a single clinic measurement. In this condition, the clinician should specifically relate management back to the presenting pattern of polyuria, polydipsia, polyphagia with weight loss, cataracts and recurrent infection. The working diagnosis should be revisited if the course becomes atypical, if expected treatment response is absent, or if new organ-system abnormalities appear. Documentation of baseline findings and the rationale for major decisions supports continuity when several clinicians or carers are involved.
Authoritative sources
- Merck Veterinary Manual — Diabetes Mellitus in Dogs and Cats
- AAHA Diabetes Management Guidelines for Dogs and Cats
- BSAVA resources and local veterinary formulary
Guidance, medicine authorisations and legal requirements change. Check the current source, product literature and jurisdiction-specific requirements before applying recommendations to an individual patient.